Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04360304
Other study ID # LOCAL/2019/CR-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 29, 2020
Est. completion date October 21, 2020

Study information

Verified date December 2020
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Acute circulatory failure (ACF) is a common cause of admission in intensive care unit (ICU). Echocardiography is a widespread tool nowadays for the initial assessment and the hemodynamic monitoring. An interesting data from this exam is the Left ventricular outflow tract (LVOT) velocity time integral (VTI), reflecting stroke volume, and therefore cardiac output. A new tool for automated recording has been developped on the VENUE GE echograph. This study aims at assessing this automated measurement of LVOT VTI compared with the classic manual method.


Description:

Acute circulatory failure is a dramatically common issue in critical care, affecting nearly 1/3 of the patients admitted in ICU, and associated with a high morbi-mortality. Echocardiography enables a quick point of care assessment of the hemodynamic status of the patient. One key parameter is stroke volume, which can be estimated by LVOT VTI. In practice, the guidelines recommend measuring LVOT VTI in a 5 chambers cavity window with pulsed wave doppler, trying to get an angle between aortic flow and the doppler signal as cloth as possible to 0°. Than VTI must be calculated from an average of 3 to 5 cycles in sinus rhythm, or 5 to 10 cycles in arrythmia such as atrial fibrillation. The main issue is that this approach is time consuming and tedious, and most of the practitioners choose to measure only the most representative beat (" Best VTI "), likely to be source of a loss of reproducibility. In order to make it easier, some companies have developed softwares to help the intensivist. Thereby, General Electric has equiped the VENUE echograph with a system that helps first selecting the proper place for sampling, and then automatically acquire, trace, and calculate the average LVOT VTI based on a 4 seconds sample. Finally, this tool gives a VTI trending when several measures are repeated along the patient' stay. This program has already been tested on a swine model in hemorrhagic shock with encouraging results (better agreement with cardiac output by thermodilution with the automated method than with the manual one). However, feasibility was only 60%. This human study aims at assessing the interest of automated LVOT VTI measurement compared to the manual standard one when performing a cardiac echography for hemodynamic assessment of patients hospitalised in ICU. Otherwise, a measure of the " Best-VTI " will be done at the same time in accordance with the current practice, in order to assess this approach. Finally, when a fluid resuscitation will be indicated, a second exam will be done, and agreement of VTI variation between automated and manual method studied.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date October 21, 2020
Est. primary completion date September 24, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient admitted in ICU and presenting an acute circulatory failure, defined by persistent hypotension (SAP < 90mmHg or MAP < 65mmHg) despite fluid resuscitation of 30ml/kg, or the need for vasopressor. - Echocardiographic hemodynamic assessment for at least one of the following signs : SAP < 90mmHg; Urine output < 0,5mL/kg/h during more than 2 hours; Blood lactate level > 2mmol/L; Increase of Norepinephrine doses needed - The patient or his trusted person / legal representative / member of the family gave his free and informed consent, et have signed the consent form, or patient included in an emergency situation. - The patient has to benefit from the French national healthcare insurance. - Age = 18 years old. Exclusion Criteria: - Participation in another study, or exclusion period from another study assessing the same primary endpoint. - Patient placed under judicial protection, or guardianship - Patient or his trusted person refuses to sign consent form - Pregnant, parturient, or breastfeeding woman - Patient with poor echogenic window

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Echocardiographic exam
An echocardiographic exam is realised after inclusion, measuring especially : LVOT VTI Respiratory variation of inferior veina cava diameter For theses two measurements, the manual method is first recorded, and then the automated one is done. For patients that need fluid resuscitation of at least 250mL in less than 10minutes (indication at the discretion of the physician in charge of the patient), a second echocardiography is done according to the same protocol described before.

Locations

Country Name City State
France CHU de Nîmes Nîmes Gard

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary VTI measurement concordance Agreement between the average LVOT VTI obtained by the manual method, and with the automatic one, estimated through calculation of Lin's coefficient and Bland-Altman plot. DAY 0
Secondary Correlation between automated and manual method - Strength of the correlation between the automated and manual method, through estimation of correlation coefficient (Pearson or Spearman) DAY 0
Secondary Rate of inappropriate measurement by the software-1 -Number of the event: Impossibility for the device giving a estimation of mean LVOT VTI DAY 0
Secondary Rate of inappropriate measurement by the software-2 -Number of the event: < 3 spectral patterns traced in patients in sinus rhythm DAY 0
Secondary Rate of inappropriate measurement by the software-3 -Number of the event: < 5 spectral patterns traced in patients in Atrial Fibrilation DAY 0
Secondary Rate of inappropriate measurement by the software-4 -Number of the event: One or more automated spectral tracing by the machine, judged as inappropriate by the expert DAY 0
Secondary Rate of inappropriate measurement by the software-5 -Number of the event: Mean LVOT VTI obtained thanks to non-consecutive traces DAY 0
Secondary Best-VTI value concordance - Agreement between the " Best-VTI " chosen by the expert, the average VTI by manual method, and the automated VTI, assessed by Lin's coefficient and Bland-Altman plot. DAY 0
Secondary variation of VTI after fluid loading concordance - Agreement between the variation of VTI after fluid loading obtained by automated and manual method, assessed by Lin's coefficient and Bland-Altman plot. DAY 0
Secondary proportion of patients classified as preload-dependant after fluid challenge concordance - Agreement between the proportion of patients classified as preload-dependant after fluid challenge (LVOT VTI variation = 15%) by automated and manual method, assessed by calculation of Kappa coefficient. DAY 0
Secondary respiratory variation of inferior vena cava - Agreement between respiratory variation of inferior vena cava measured by automated and manual method, assessed by Lin's coefficient and Bland-Altman plot DAY 0
Secondary Rate of inappropriate measurement of respiratory variation of inferior vena cava - Rate of inappropriate measurement of respiratory variation of inferior vena cava by the software of the automated method. DAY 0
See also
  Status Clinical Trial Phase
Completed NCT03225378 - Changes in PPV Induced by PLR Test to Predict Fluid Responsiveness in ICU
Completed NCT03680963 - Early Versus Differed Arterial Catheterization in Critically Ill Patients With Acute Circulatory Failure: N/A
Terminated NCT01090791 - FLOTRAC/VIGILEO in Acute Circulatory Failure N/A
Completed NCT04337983 - Hemodynamic Characteristics of Patients With SARS-CoV-2
Recruiting NCT04946643 - Subclavian Vein Diameter Variations to Assess Vascular Filling
Recruiting NCT03788772 - Systems Analysis of Antigen Presenting Cells in Human Sepsis N/A
Completed NCT02050269 - Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study Phase 3
Completed NCT01630577 - Central Venous Pressure Change With Volume Challenge in Patients With Hemodynamic Instability Phase 3
Recruiting NCT05046340 - Applicability of Fluid Responsiveness Indices in Circulatory Failure (AFRIC Study) Study Project
Completed NCT04250389 - Microcirculatory Effects of Methylene Blue
Recruiting NCT05613647 - Concordance Study of Therapeutic Decision-making in Patients With Shock Based on Hemodynamic Monitoring
Completed NCT05847998 - Second Generation DICART Prototype Validation N/A
Not yet recruiting NCT06384287 - Peripheral Tissue Perfusion in Intensive Care
Recruiting NCT02878369 - Evaluation of Doppler Flow From the Femoral Artery as a Reflection of Cardiac Flow in a Vascular Fluid Test N/A
Completed NCT03694717 - Time Course Evolution of Cardiac Output